Clinical Trial Update: The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial updates on erythropoietin (EPO) evaluating its effect on transfusion requirements in very low birth weight infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Neonatal
• Infant Low Birth Weight
• Infant Newborn
• Infant Premature
• Infant Small For Gestational Age

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Infant, Newborn, Infant, Low Birth Weight | Phase 2, Phase 3 | Status: COMPLETED